Your session is about to expire
← Back to Search
Diagnostic Test
BVA-100 for Heart Failure
N/A
Waitlist Available
Led By Jacob Joseph
Research Sponsored by Daxor Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days post discharge
Awards & highlights
Study Summary
This trial is testing whether using a machine to directly measure blood volume in addition to usual care results in more appropriate treatment and better patient outcomes.
Eligible Conditions
- Acute Heart Failure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days post discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post discharge
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Quantitative assessment of progress to euvolemic target for both subjects and controls
Secondary outcome measures
Quantitative assessment of continuous outcome metrics: natriuretic peptide
Quantitative assessment of continuous outcome metrics: net fluid balance
Quantitative assessment of continuous outcome metrics: weight
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Standard care groupExperimental Treatment1 Intervention
Blood Volume Analysis will be performed at admission, during inpatient stay if warranted, and prior to hospital discharge. Treating physicians will be blinded to the results and will choose between a low-moderate and high diuretic dose based on usual care clinical assessment of volume status.
Group II: BVA-guided treatment armExperimental Treatment1 Intervention
Blood Volume Analysis will be performed at admission, during inpatient stay if warranted, and prior to hospital discharge. Treating physicians will receive the results and will choose between a low-moderate and high diuretic dose based on measured volume status.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BVA-100
2020
N/A
~90
Find a Location
Who is running the clinical trial?
Daxor CorporationLead Sponsor
12 Previous Clinical Trials
297 Total Patients Enrolled
7 Trials studying Heart Failure
186 Patients Enrolled for Heart Failure
VA Boston Healthcare SystemFED
69 Previous Clinical Trials
970,460 Total Patients Enrolled
Minneapolis Veterans Affairs Medical CenterFED
73 Previous Clinical Trials
15,048 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger